Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDN
1951
Brandywine Realty Trust
BDN
$782M
| $1.52M | ﹤0.01% |
339,200
| – | – |
|
|
LBPH
1952
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.52M | ﹤0.01% |
56,200
+13,900
| +33% | +$376K |
|
|
FBMS
1953
DELISTED
The First Bancshares, Inc.
FBMS
| $1.52M | ﹤0.01% |
58,430
+3,200
| +6% | +$83.1K |
|
1954
Gorman-Rupp
GRC
$1.15B
| $1.51M | ﹤0.01% |
41,247
-2,700
| -6% | -$99.1K |
|
1955
Liberty Live Group Series A
LLYVA
$9.09B
| $1.51M | ﹤0.01% |
40,276
| – | – |
|
1956
Atlas Energy Solutions
AESI
$1.35B
| $1.51M | ﹤0.01% |
75,700
+36,200
| +92% | +$721K |
|
1957
BlueLinx
BXC
$651M
| $1.51M | ﹤0.01% |
16,200
-1,100
| -6% | -$102K |
|
1958
Arcus Biosciences
RCUS
$1.22B
| $1.5M | ﹤0.01% |
98,296
+2,900
| +3% | +$44.2K |
|
1959
PC Connection
CNXN
$1.65B
| $1.5M | ﹤0.01% |
23,300
| – | – |
|
1960
Energy Recovery
ERII
$773M
| $1.49M | ﹤0.01% |
112,300
+1,200
| +1% | +$15.9K |
|
|
ETWO
1961
DELISTED
E2open Parent Holdings
ETWO
| $1.49M | ﹤0.01% |
332,300
| – | – |
|
1962
Camping World
CWH
$1.1B
| $1.49M | ﹤0.01% |
83,500
| – | – |
|
1963
Shenandoah Telecom
SHEN
$752M
| $1.49M | ﹤0.01% |
91,172
-2,900
| -3% | -$47.4K |
|
1964
Bank First Corp
BFC
$1.26B
| $1.49M | ﹤0.01% |
18,017
+600
| +3% | +$49.6K |
|
1965
Perella Weinberg Partners
PWP
$1.45B
| $1.49M | ﹤0.01% |
91,500
+1,100
| +1% | +$17.9K |
|
1966
Vicor
VICR
$2.29B
| $1.49M | ﹤0.01% |
44,832
| – | – |
|
1967
IMAX
IMAX
$1.71B
| $1.48M | ﹤0.01% |
88,500
-2,900
| -3% | -$48.6K |
|
|
HAYN
1968
DELISTED
Haynes International, Inc.
HAYN
| $1.47M | ﹤0.01% |
25,100
| – | – |
|
1969
Archer Aviation
ACHR
$5.48B
| $1.47M | ﹤0.01% |
418,500
+41,900
| +11% | +$147K |
|
1970
Kiniksa Pharmaceuticals
KNSA
$2.74B
| $1.47M | ﹤0.01% |
78,600
+23,000
| +41% | +$429K |
|
1971
Alignment Healthcare
ALHC
$3.24B
| $1.47M | ﹤0.01% |
187,600
-16,600
| -8% | -$130K |
|
|
BRSP
1972
BrightSpire Capital
BRSP
$772M
| $1.46M | ﹤0.01% |
256,200
| – | – |
|
1973
Cellebrite
CLBT
$4.2B
| $1.46M | ﹤0.01% |
122,100
+24,500
| +25% | +$293K |
|
|
BRKL
1974
DELISTED
Brookline Bancorp
BRKL
| $1.46M | ﹤0.01% |
174,700
| – | – |
|
|
AHH
1975
Armada Hoffler Properties
AHH
$596M
| $1.46M | ﹤0.01% |
131,400
-2,500
| -2% | -$27.7K |
|